{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T21:19:37Z","timestamp":1781039977168,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science and Technology Belgium (IWT)","award":["IWT 70699"],"award-info":[{"award-number":["IWT 70699"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejca.2016.09.021","type":"journal-article","created":{"date-parts":[[2016,10,29]],"date-time":"2016-10-29T02:45:20Z","timestamp":1477709120000},"page":"9-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7128-1354","authenticated-orcid":false,"given":"Maria E.","family":"Goossens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice P.","family":"Zeegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7458-8578","authenticated-orcid":false,"given":"Hendrik","family":"van Poppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Joniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Ackaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7445-0803","authenticated-orcid":false,"given":"Filip","family":"Ameye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace","family":"Billiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Braeckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5749-6332","authenticated-orcid":false,"given":"Alex","family":"Breugelmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Darras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Dilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Goeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Tombal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siska","family":"Van Bruwaene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Van Cleyenbreugel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Van der Aa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Vekemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Buntinx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2016.09.021_bib1","series-title":"GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet]","author":"Ferlay","year":"2013"},{"key":"10.1016\/j.ejca.2016.09.021_bib2","series-title":"Belgium cancer registry, Brussels","author":"Cancer incidence in Belgium","year":"2008"},{"issue":"3","key":"10.1016\/j.ejca.2016.09.021_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.urology.2007.10.056","article-title":"Clinical model of cost of bladder cancer in the elderly","volume":"71","author":"Cooksley","year":"2008","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ejca.2016.09.021_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S1020-49892005000600001","article-title":"Cancer mortality in Latin America: implications for prevention","volume":"18","author":"Bosetti","year":"2005","journal-title":"Rev Panam Salud Publica"},{"issue":"9","key":"10.1016\/j.ejca.2016.09.021_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S1470-2045(06)70862-2","article-title":"Use of selenium in chemoprevention of bladder cancer","volume":"7","author":"Brinkman","year":"2006","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2016.09.021_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/07315724.2002.10719214","article-title":"Selenocompounds in plants and animals and their biological significance","volume":"21","author":"Whanger","year":"2002","journal-title":"J Am Coll Nutr"},{"issue":"10","key":"10.1016\/j.ejca.2016.09.021_bib7","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2174\/138955708785740625","article-title":"Selenium compounds and apoptotic modulation: a new perspective in cancer therapy","volume":"8","author":"Sanmartin","year":"2008","journal-title":"Mini Rev Med Chem"},{"issue":"12","key":"10.1016\/j.ejca.2016.09.021_bib8","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00204-010-0595-8","article-title":"Selenium: a double-edged sword for defense and offence in cancer","volume":"84","author":"Brozmanova","year":"2010","journal-title":"Arch Toxicol"},{"issue":"7","key":"10.1016\/j.ejca.2016.09.021_bib9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2174\/138955708784567368","article-title":"Organoselenium compounds in cancer chemoprevention","volume":"8","author":"Naithani","year":"2008","journal-title":"Mini Rev Med Chem"},{"issue":"9","key":"10.1016\/j.ejca.2016.09.021_bib10","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1442-2042.2006.01526.x","article-title":"Selenium is inversely associated with bladder cancer risk: a report from the Belgian case-control study on bladder cancer","volume":"13","author":"Kellen","year":"2006","journal-title":"Int J Urol"},{"issue":"4","key":"10.1016\/j.ejca.2016.09.021_bib11","first-page":"186","article-title":"Serum selenium levels in various cancer types","volume":"12","author":"Torun","year":"1995","journal-title":"Trace Elem Electrocytes"},{"issue":"6","key":"10.1016\/j.ejca.2016.09.021_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1464-410X.2003.04729.x","article-title":"The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder","volume":"93","author":"Yalcin","year":"2004","journal-title":"BJU Int"},{"issue":"21","key":"10.1016\/j.ejca.2016.09.021_bib13","first-page":"6144","article-title":"Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer","volume":"49","author":"Helzlsouer","year":"1989","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.ejca.2016.09.021_bib14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/sj.bjc.6602788","article-title":"Toenail selenium concentrations and bladder cancer risk in women and men","volume":"93","author":"Michaud","year":"2005","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.ejca.2016.09.021_bib15","first-page":"1505","article-title":"No association between toenail selenium levels and bladder cancer risk","volume":"11","author":"Michaud","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.ejca.2016.09.021_bib16","first-page":"103","article-title":"Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data","volume":"79","author":"Nomura","year":"1987","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"10.1016\/j.ejca.2016.09.021_bib17","first-page":"1292","article-title":"Prediagnostic toenail selenium and risk of bladder cancer","volume":"11","author":"Zeegers","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2016.09.021_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005195.pub2","article-title":"Selenium for preventing cancer","volume":"5","author":"Dennert","year":"2011","journal-title":"Cochrane Database Syst Rev [Internet]"},{"issue":"5","key":"10.1016\/j.ejca.2016.09.021_bib19","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/j.juro.2006.07.004","article-title":"Chemoprevention for bladder cancer","volume":"176","author":"Busby","year":"2006","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ejca.2016.09.021_bib20","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00120-007-1348-z","article-title":"Primary prevention of bladder cancer. What's new?","volume":"46","author":"Altwein","year":"2007","journal-title":"Urol A"},{"issue":"Suppl. 218","key":"10.1016\/j.ejca.2016.09.021_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/03008880802284258","article-title":"Bladder cancer: chemoprevention, complementary approaches and budgetary considerations","volume":"42","author":"Grossman","year":"2008","journal-title":"Scand J Urology Nephrol"},{"issue":"9","key":"10.1016\/j.ejca.2016.09.021_bib22","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1158\/1055-9965.EPI-10-0544","article-title":"Selenium and bladder cancer risk: a meta-analysis","volume":"19","author":"Amaral","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ejca.2016.09.021_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2490-12-8","article-title":"Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium","volume":"12","author":"Goossens","year":"2012","journal-title":"BMC Urol"},{"issue":"1","key":"10.1016\/j.ejca.2016.09.021_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ejca.2016.09.021_bib25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2008.04.051","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder","volume":"54","author":"Babjuk","year":"2008","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.ejca.2016.09.021_bib26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejca.2016.09.021_bib27","series-title":"Common Terminology criteria for adverse events, version 3.0, DCTD, NCI, NIH, DHHS March 31","author":"Cancer Therapy Evaluation Program","year":"2003"},{"issue":"12","key":"10.1016\/j.ejca.2016.09.021_bib28","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2016.09.021_bib29","series-title":"WHO classification of classification of tumors of the urinary system and male genital organs Lyon","first-page":"29","article-title":"Tumours of the urinary system: non-invasive urothelial neoplasias","author":"Sauter","year":"2004"},{"key":"10.1016\/j.ejca.2016.09.021_bib30","series-title":"TNM classification of malignant tumors. UICC International Union against Cancer","first-page":"262","year":"2009"},{"issue":"3","key":"10.1016\/j.ejca.2016.09.021_bib31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ejca.2016.09.021_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","article-title":"An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer","volume":"56","author":"Malmstrom","year":"2009","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ejca.2016.09.021_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/jaoac\/87.1.225","article-title":"Speciation and bioavailability of selenium in yeast-based intervention agents used in cancer chemoprevention studies","volume":"87","author":"Larsen","year":"2004","journal-title":"J AOAC Int"},{"issue":"4","key":"10.1016\/j.ejca.2016.09.021_bib34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1079\/BJN20041251","article-title":"The use of high-selenium yeast to raise selenium status: how does it measure up?","volume":"92","author":"Rayman","year":"2004","journal-title":"Br J Nutr"},{"issue":"1","key":"10.1016\/j.ejca.2016.09.021_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2008.864","article-title":"Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E cancer prevention trial (SELECT)","volume":"301","author":"Lippman","year":"2009","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ejca.2016.09.021_bib36","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.juro.2012.01.117","article-title":"Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT","volume":"187","author":"Lotan","year":"2012","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ejca.2016.09.021_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/mi.9.1.6","article-title":"The outcome of selenium and vitamin E cancer prevention trial (SELECT) reveals the need for better understanding of selenium biology","volume":"9","author":"Hatfield","year":"2009","journal-title":"Mol Interv"},{"issue":"19","key":"10.1016\/j.ejca.2016.09.021_bib38","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/jnci\/djp272","article-title":"Re: selenium and vitamin E: interesting biology and dashed hope","volume":"101","author":"Goossens","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.ejca.2016.09.021_bib39","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1464-410X.2009.08849.x","article-title":"The West Midlands Bladder Cancer Prognosis Programme: rationale and design","volume":"105","author":"Zeegers","year":"2009","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ejca.2016.09.021_bib40","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1371\/journal.pmed.0050067","article-title":"Observational research, randomised trials, and two views of medical science","volume":"5","author":"Vandenbroucke","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejca.2016.09.021_bib41","doi-asserted-by":"crossref","first-page":"19213","DOI":"10.1038\/srep19213","article-title":"Selenium exposure and cancer risk: an updated meta-analysis and meta-regression","volume":"6","author":"Cai","year":"2016","journal-title":"Sci Rep"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916324522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804916324522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T01:16:12Z","timestamp":1601169372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804916324522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":41,"alternative-id":["S0959804916324522"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2016.09.021","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2016.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}